ADB-5'Br-PINACA
ADB-5'Br-PINACA is a designer drug that belongs to the cannabinoid class. It is an analog of ADB-PINACA which includes a bromine atom on the terminal carbon of the pentyl chain. ADB-5'Br-PINACA was first identified in Estonia in 2019, and it has been sold online as a designer drug.
Chemistry[edit | edit source]
ADB-5'Br-PINACA is a synthetic cannabinoid that is structurally related to the natural cannabinoid THC. It is an analog of ADB-PINACA, with the pentyl chain substituted with a bromine atom. The exact molecular formula of ADB-5'Br-PINACA is C18H20BrN4O2.
Pharmacology[edit | edit source]
The pharmacology of ADB-5'Br-PINACA is not well understood. However, it is known to act as a potent agonist for the CB1 receptor, which is responsible for its psychoactive effects. The exact mechanism of action and the full spectrum of effects of ADB-5'Br-PINACA are still under investigation.
Legal Status[edit | edit source]
ADB-5'Br-PINACA is a controlled substance in some countries due to its potential for abuse and the lack of medical use. In the United States, it is a Schedule I controlled substance. In the European Union, it is a controlled substance under the Psychoactive Substances Act.
See Also[edit | edit source]
References[edit | edit source]
ADB-5'Br-PINACA Resources | ||
---|---|---|
|
|
Translate to: East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.Contributors: Prab R. Tumpati, MD